Surrogate Endpoints in Evaluating the Effectiveness of Drugs Against HIV Infection and AIDS (1990)

Chapter: Special Issues in the Maternal and Pediatric Population

Previous Chapter: Immunologic Markers
Suggested Citation: "Special Issues in the Maternal and Pediatric Population." National Research Council. 1990. Surrogate Endpoints in Evaluating the Effectiveness of Drugs Against HIV Infection and AIDS. Washington, DC: The National Academies Press. doi: 10.17226/20864.
Page 7
Suggested Citation: "Special Issues in the Maternal and Pediatric Population." National Research Council. 1990. Surrogate Endpoints in Evaluating the Effectiveness of Drugs Against HIV Infection and AIDS. Washington, DC: The National Academies Press. doi: 10.17226/20864.
Page 8
Suggested Citation: "Special Issues in the Maternal and Pediatric Population." National Research Council. 1990. Surrogate Endpoints in Evaluating the Effectiveness of Drugs Against HIV Infection and AIDS. Washington, DC: The National Academies Press. doi: 10.17226/20864.
Page 9
Next Chapter: Endpoints, Trial Design, and Regulation
Subscribe to Emails from the National Academies
Stay up to date on activities, publications, and events by subscribing to email updates.